The latest publications from the FSA and FSS Cell-Cultivated Products Sandbox Programme aim to give developers a clearer and more predictable path to market authorisation, while keeping consumer safety at the heart of the regulatory process.
Businesses developing cell-cultivated food products in Great Britain have been given new guidance on navigating the regulatory approval process, as the Food Standards Agency (FSA) and Food Standards Scotland (FSS) publish the latest package from their Cell-Cultivated Products Sandbox Programme.
The guidance spans regulatory authorisation as well as the assessment of growth media components and toxicology. Together, the documents aim to give developers a better understanding of how existing food regulations apply to cell-cultivated products and what evidence they will need to provide before products can be authorised for sale.
The latest publications are the third batch of guidance produced through the Sandbox Programme, which launched in February 2025 and is due to run until February 2027.
Clarifying the route to market
The regulatory authorisation guidance explains how the regulated products framework applies to cell-cultivated products. It also provides advice on how businesses should handle changes to a product after it has received authorisation.
The second document focuses on growth media, which provide the nutrients and other conditions required to grow cells during the production process. It sets out scientific guidance for assessing potential safety hazards associated with components used in growth media and is intended to support companies preparing dossiers for regulatory review.
Each batch of guidance we publish makes the path to market authorisation clearer and more predictable for companies developing cell-cultivated products, while ensuring consumer safety remains at the core of everything we do. Through the Sandbox programme, we’re building a shared understanding of how food regulations apply to genuinely novel products, and turning that understanding into practical guidance the whole sector can benefit from.”
Dr Thomas Vincent, Deputy Director of Innovation at the FSA
UPCOMING WEBINAR | Human safety assessment for novel foods: De-risking the path from concept to compliance
Bringing new food ingredients from concept to market requires robust evidence around safety, testing and regulatory compliance.
Join our upcoming webinar on 8 October 2026 at 3pm BST to explore how tiered safety assessment strategies can help developers identify risks earlier, strengthen regulatory submissions and de-risk the route to market.
Building regulatory understanding
Through the Sandbox Programme, the FSA and FSS work directly with businesses developing cell-cultivated products to explore how existing food regulations apply to the technology.
The aim is to use the knowledge gained through these discussions to develop practical guidance that can be applied by the wider industry. The latest package therefore builds on previous work intended to help businesses understand the regulatory process and prepare stronger applications for market authorisation.
Cell-cultivated products are made by growing animal cells under controlled conditions rather than producing food through conventional livestock farming. Developers are exploring the technology as a potential way to produce meat and other animal-derived foods.
As the sector develops, regulators face the challenge of applying existing food safety requirements to products and production methods that are relatively new.
Research adds to evidence base
The FSA has also published research examining scientific issues relevant to the safety assessment of cell-cultivated products.
This includes a review of analytical methods that can be used to assess cell-cultivated products and research examining how genetic drift could affect their safety.
The research is intended to help businesses considering what scientific evidence should be included in applications for market authorisation.
The FSA and FSS say the latest guidance will help businesses better understand the standards they need to meet while keeping consumer safety at the centre of the authorisation process.
Businesses can access the Sandbox guidance through the FSA’s Innovative Foods Guidance Hub. Companies developing cell-cultivated products can also request support with their market authorisation applications through the Sandbox Business Support Service.
No comments yet